compound, methods for treating atherosclerosis, for increasing hdl-c, for reducing p ldl-c and for treating dyslipidemia in a patient, and, use of compound, pharmaceutical composition
DEYOU SHA,FENG YE,JIAN LIU,PENGCHENG PATRICK SHAO,PETR VACHAL,REVATHI REDDY KATIPALLY,WANYING SUN
申请号:
BR112014010204
公开号:
BR112014010204A2
申请日:
2012.10.25
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.